Physiologically-based pharmacokinetic (PBPK) modeling and simulations principles, methods, and applications in the pharmaceutical industry /
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Kaituhi rangatōpū: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hoboken, N.J. :
Wiley,
c2011.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- Modelling in the pharmaceutical industry
- Physiologically-based modelling
- A review of pharmacokinetic principles
- Physiological model for absorption
- Physiological model for distribution
- Physiological models for drug metabolism and excretion
- Generic whole-body physiologically-based pharmacokinetic modelling
- Variability, uncertainty and sensitivity analysis
- Evaluation of drug-drug interaction risk with pbpk models
- PBPK of biotherapeutics
- Data integration and sensitivity analysis
- Hypothesis generation and pharmacokinetic predictions
- Integration of PBPK and pharmacodynamics
- PBPK modelling of populations
- PBPK models along the drug discovery and development value chain.